• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sage Therapeutics Inc

+ Add to Watchlist

SG7:GR

31.328 EUR 0.617 2.01%

As of 12:59:49 ET on 11/25/2014.

Snapshot for Sage Therapeutics Inc (SG7)

Open: 31.261 Day's Range: 30.972 - 31.328 Volume: 0
Previous Close: 30.711 52wk Range: 18.700 - 31.500 1-Yr Rtn: -

Stock Chart for SG7

No chart data available.
  • SG7:GR 31.116
  • 1D
  • 1M
  • 1Y
30.711
Interactive SG7 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SG7

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.5650
Est. PEG Ratio -
Market Cap (M EUR) 808.03
Shares Outstanding (M) 25.79
30 Day Average Volume 14
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SG7

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SG7

Sage Therapeutics, Inc. develops treatments for central nervous system disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Sage Therapeutics operates in the United States.

Jeffrey M Jonas "Jeff"President/CEOKimi IguchiChief Financial Officer
Stephen J KanesChief Medical OfficerAlbert J RobichaudChief Scientific Officer
More Company Profile & Key Executives for SG7

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil